Atopic Dermatitis Across Skin Tones: Diagnosis & Management Nuances

Why Skin Tone Matters in AD

Atopic dermatitis (AD) presentation varies by melanin content. Traditional descriptors (erythema, “red” patches) under‑detect inflammation in darker skin, leading to delayed diagnosis, undertreatment, and health disparities.

Clinical Presentation by Skin Phototype

Feature	Light Skin (Fitzpatrick I–III)	Dark Skin (Fitzpatrick IV–VI)
Acute Inflammation	Bright red, well‑demarcated plaques	Dark brown, violaceous, or grayish patches; erythema masked
Chronic Lichenification	Thickened, hyperpigmented, excoriated	Hyperpigmented (post‑inflammatory), lichenoid papules
Follicular Accentuation	Less prominent	Common: follicular papules on trunk/extensor surfaces
Pruritus	Often dominant complaint	Equally intense; may present as “prurigo nodularis” morphology
Distribution	Flexural (antecubital, popliteal)	Extensor, follicular, periorbital, perioral

Diagnostic Pearls for Darker Skin

• Use tangential lighting / dermatoscopy to appreciate erythema (blanching).
• Palpate for warmth, induration, scale.
• Ask about “ashy” appearance, color change, itch quality.
• Consider EASI‑skin tone adjusted scoring tools.

Treatment Principles (Same Across Tones)

• Skin Barrier Repair: Fragrance‑free emollients ≥2×/day (ceramides, petrolatum).
• Topical Anti‑Inflammatories: Corticosteroids (potency matched to site/severity), calcineurin inhibitors (tacrolimus, pimecrolimus), PDE4 inhibitor (crisaborole), JAK inhibitor (ruxolitinib cream).
• Proactive Therapy: Twice‑weekly low‑potency steroid on previously active sites prevents flares.
• Systemics for Moderate‑Severe: Dupilumab, tralokinumab, upadacitinib, abrocitinib, methotrexate, cyclosporine, azathioprine.
• Phototherapy: NB‑UVB effective; adjust dose for skin type.

Addressing Post‑Inflammatory Hyperpigmentation (PIH)

• PIH disproportionately affects patients of color; causes distress.
• Early inflammation control = best PIH prevention.
• Topical agents: azelaic acid, niacinamide, retinoids, hydroquinone (short course), tranexamic acid.
• Sunscreen (tinted mineral SPF 30+) essential.

Health‑Equity Actions

• Diverse clinical images in education / EHR.
• Provider training on skin‑of‑color dermatology.
• Community outreach, multilingual materials.
• Research inclusion: stratified enrollment, outcomes by race/ethnicity.